News and Press Releases
Sanofi launches high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK
Developed with a higher antigen content to increase protection in older adults, a population at greater risk of severe complications from infection. Now available and can be pre-ordered for the...
Category: Pharmaceutical
Posted: October 17, 2024
Antiverse raises £3.5M ($4.6M) to advance generative AI antibody design platform
Increases total equity financing raised to £7.2M ($10.1M) New facilities in Boston and Prague will provide increased capacity to deliver pipeline of pharma and biotech projects Funding to progress internal...
Category: Biotechnology, Drug Discovery
Posted: October 17, 2024
AscellaHealth Announces its Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services
17 October 2024 -- Pennsylvania, US and Watford, UK -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces the acquisition of CHAPPER healthcare, a...
Category:
Posted: October 17, 2024
AscellaHealth, LLC 1055 Westlakes Drive Suite 175 Berwyn, PA 19312, US
SciRhom Initiates Dosing in First-in-Man Clinical Study Evaluating the Company’s Lead Development Program SR-878
Transition into clinical-stage development marks a significant corporate and R&D milestone 17 October 2024 -- Munich, Germany -- SciRhom GmbH, a biopharmaceutical company pioneering the development of first-in-class therapeutic iRhom2...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 17, 2024
Publication Demonstrates Potential for Multi-Marker CTC Profiling in Early Prostate Cancer
Parsortix enriched CTCs detected at high rates in localised disease Multi-marker profiling of CTCs could support development of targeted therapies and help stratify patients in clinical trials 17 October 2024...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 17, 2024
Sanofi and Orano join forces to develop next-generation radioligand medicines
17 October 2024 -- Paris, France -- Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 17, 2024
MC Services is Media Partner for BIO-Europe® 30th Anniversary in Stockholm
15 October, 2024 – Munich / Düsseldorf, Germany – MC Services AG, a leading international public and investor relations firm specializing in communications for the life sciences and healthcare sectors,...
Category: Other
Posted: October 16, 2024
SIRIO opens €16M full-service packaging facility on German site
New facility’s automated packaging lines provide annual filling capacity for 20 million blisters and 5 million bottles 15 October 2024 – SIRIO Pharma (SIRIO®) – the global nutraceutical contract development...
Category: Manufacturing and Packing
Posted: October 16, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
Regulatory and Compliance excellence recognized for innovation across the product development lifecycle 9 October 2024 – Raleigh, NC, US – ProPharma, a leading global provider of regulatory, clinical, and compliance...
Category: Manufacturing and Packing, Pharmaceutical
Posted: October 16, 2024
TekniPlex Healthcare Becomes First to Introduce Medical-grade, ISCC PLUS-certified Bio-based PVC Compounds Equivalent to Conventional PVC
Company’s bio-based compounds are a drop-in replacement for a variety of injection molded or extruded medical-grade PVC compounds utilized in tubing, films, components and other applications. 3 October 2024 –Wayne,...
Category: BioManufacturing, Manufacturing and Packing
Posted: October 16, 2024
Industrielaan 37 B-9320 Erembodegem Belgium Tel: +32 (0)53 650711 VAT 0425.537.515
OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain
Neuropathic corneal pain (NCP) is listed in the National Organization for Rare Disorders (NORD) as an orphan disease OKYO is the first company to have an IND application granted by...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 16, 2024
HUTCHMED Announces that TAGRISSO plus ORPATHYS demonstrated high,clinically meaningful response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial
New data demonstrate efficacy for the oral treatment combination to address MET-driven resistance in EGFR-mutated lung cancer MET is a common biomarker in this setting for patients who develop resistance...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 16, 2024
£4.5 million project launched to tackle acute skills shortage in UK medicines manufacturing
Resilience, the UK’s first Medicines Manufacturing Skills Centre of Excellence, will use virtual reality to train in laboratory skills and support the NHS’ net-zero goal 16 October 2024 -- Birmingham,...
Category: Biotechnology, Other, Pharmaceutical
Posted: October 16, 2024
UK Research and Innovation Polaris House Swindon SN2 1FL
Bespak & H&T Presspart announce availability of GMP pilot line for low GWP pMDIs
Filling line is on track to supply clinical trial batches utilising climate-friendly propellants HFA-152a and HFO-1234ze 8 October 2024 – Holmes Chapel, UK, and Blackburn, UK – Bespak, a specialist...
Category: Drug Delivery
Posted: October 16, 2024
Cellular Origins, Fresenius Kabi Sign Development Agreement for Scalable Automation of Cell and Gene Therapy Manufacturing
Companies to develop integration strategies for Fresenius Kabi’s portfolio of Cell Therapy Technologies within Cellular Origins’ Constellation automation platform Initial research to focus on integration of the Cue Cell Processing...
Category: Biotechnology, Manufacturing and Packing, Other, Pharmaceutical
Posted: October 16, 2024
